000 | 01542 a2200445 4500 | ||
---|---|---|---|
005 | 20250515131919.0 | ||
264 | 0 | _c20090323 | |
008 | 200903s 0 0 eng d | ||
022 | _a1502-7732 | ||
024 | 7 |
_a10.1080/03009740802179701 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBecker, H | |
245 | 0 | 0 |
_aPotential role of macrophage migration inhibitory factor in adult-onset Still's disease. _h[electronic resource] |
260 |
_bScandinavian journal of rheumatology _c |
||
300 |
_a69-71 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aEtanercept |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFerritins _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
650 | 0 | 4 |
_aIntramolecular Oxidoreductases _xblood |
650 | 0 | 4 |
_aMacrophage Migration-Inhibitory Factors _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aStill's Disease, Adult-Onset _xblood |
700 | 1 | _aGaubitz, M | |
700 | 1 | _aDomschke, W | |
700 | 1 | _aWilleke, P | |
773 | 0 |
_tScandinavian journal of rheumatology _gvol. 38 _gno. 1 _gp. 69-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/03009740802179701 _zAvailable from publisher's website |
999 |
_c18160724 _d18160724 |